Baxter PS, Hardingham GE
Overall, PQQ may facilitate obesity treatment as research in the field of study progresses
22 Eight obese women reported reduced hunger following subcutaneous injections of exenatide and it was related with an enhanced functional connectivity of the nucleus tractus solitarius with the thalamus and hypothalamus
Back to Journals Risk Management and Healthcare Policy Volume 17 Health Technology Assessment: Evaluation of 7 Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus Authors Xie Z , Hu J, Li M, Hu X , Chen J Received 20 December 2023 Accepted for publication 17 April 2024 Published 23 April 2024 Volume 2024:17 Pages 10531067 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Jongwha Chang Zeyu Xie, Jia Hu, Mengting Li, Xiao Hu, Jisheng Chen Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, Peoples Republic of China Correspondence: Jisheng Chen, Key Specialty of Clinical Pharmacy, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, Peoples Republic of China, Tel +86 20-87622305, Fax +86 20-61321967, Email [email protected] Purpose: This study provides a reference for healthcare organizations in the selection and rational use of glucagon-like peptide-1 receptor agonists (GLP-1RAs), based on the Rapid Guide for Drug Evaluation and Selection in Chinese Medical Institutions (Second Edition)
For individuals with absorption disorders or pernicious anemia, this direct delivery method is often the preferred route
